Privia Health Group, Inc. (PRVA)
Health Care / Health Care Services
S&P SmallCap 600$21.07
Scores poorly across most models. Proceed with caution.
Weak
Score based on 4 of 5 models — moderate confidence
Is Privia Health Group, Inc. a Good Investment in 2026?
Privia Health Group, Inc. (PRVA) scores 3.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates Privia Health Group, Inc. as Attractive (5/9). However, the Graham model rates it Caution — Significantly above fair value. Privia Health Group, Inc. ranks #972 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 118x earnings — significantly above sector median of 25x. Premium reflects market growth expectations.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Neutral
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Attractive
High PEG — growth premium · Stalwart
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is Privia Health Group, Inc. (PRVA) a good investment?
What is Privia Health Group, Inc.'s Piotroski F-Score?
Is PRVA overvalued or undervalued?
How does PRVA compare to other Health Care stocks?
What do investment models say about PRVA?
Similar Stocks
Compare PRVA with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer